Evidence map›Paper›PMID 33603166›Full record

ArticleOncogene2021

Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis.

Rochelle Fletcher, Jingshan Tong, Denise Risnik, Brian J Leibowitz, Yi-Jun Wang, Fernando Concha-Benavente, Jonathan M DeLiberty, Donna B Stolz, Reet K Pai, Robert L Ferris and 3 more

Open access · greenAbstract read
In one paragraph

Article in Oncogene, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Targeting Myc-driven stress addiction in colorectal cancer.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 2023
    Review
  7. Review
  8. Platinum(IV) Derivatives of [Pt(1Journal of medicinal chemistry · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Immunogenic Cell Death-Based Cancer Vaccines.Frontiers in immunology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Rochelle FletcherUPMC Hillman Cancer Center, Pittsburgh, PA, USA.
Jingshan TongUPMC Hillman Cancer Center, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0003-1640-5769
Denise RisnikUPMC Hillman Cancer Center, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0001-8843-7968
Brian J LeibowitzUPMC Hillman Cancer Center, Pittsburgh, PA, USA.
Yi-Jun WangUPMC Hillman Cancer Center, Pittsburgh, PA, USA.
Fernando Concha-BenaventeUPMC Hillman Cancer Center, Pittsburgh, PA, USA.
Jonathan M DeLibertyDepartment of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Donna B StolzUPMC Hillman Cancer Center, Pittsburgh, PA, USA.
Reet K PaiUPMC Hillman Cancer Center, Pittsburgh, PA, USA.
Robert L FerrisUPMC Hillman Cancer Center, Pittsburgh, PA, USA.
Robert E SchoenUPMC Hillman Cancer Center, Pittsburgh, PA, USA.
Jian YuUPMC Hillman Cancer Center, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-4021-1000
Lin ZhangUPMC Hillman Cancer Center, Pittsburgh, PA, USA. zhanglx@upmc.edu.ORCID http://orcid.org/0000-0003-0018-3903
University of Pittsburgh · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
Training and EducationU19AI068021 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GREENBERGER, JOEL S · 2005 to 2019
$44.4M
Refinement and Discovery of Nuclear Matrix Protein Markers for Colorectal CancerU01CA152753 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KINZLER, KENNETH W., SCHOEN, ROBERT E. · 2010 to 2021
$6.8M
Novel Mcl-1 inhibitors for overcoming therapeutic resistance in colorectal cancerR01CA217141 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NIKOLOVSKA-COLESKA, ZANETA, ZHANG, LIN · 2017 to 2021
$2.6M
LR-IL-22 for Mitigation and Management of Radiation InjuriesU01AI172885 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOEL S GREENBERGER · 2023 to 2026
$2.4M
Translation addiction and targeting in colon cancerR01CA215481 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YU, JIAN · 2018 to 2022
$2.3M
Targeting defective necroptosis in colorectal cancerR01CA247231 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ZHANG, LIN · 2020 to 2024
$2.3M
Role of necroptosis in colorectal cancer therapyR01CA236271 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ZHANG, LIN · 2019 to 2023
$2.2M
Role of Mcl-1 degradation in colorecal cancer therapyR01CA203028 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZHANG, LIN · 2016 to 2020
$1.7M
Bid-mediated killing of oncogenic stem cells in chemopreventionR01CA172136 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZHANG, LIN · 2013 to 2017
$1.6M
NCI NIH HHS P30 CA047904NCI NIH HHS R01 CA172136NCI NIH HHS R01 CA203028NCI NIH HHS R01 CA215481NCI NIH HHS R01 CA217141NCI NIH HHS R01 CA236271NCI NIH HHS R01 CA247231NCI NIH HHS U01 CA152753NIAID NIH HHS U01 AI172885NIAID NIH HHS U19 AI068021
6 · The paper itself

Abstract

Use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with reduced risk of colorectal cancer (CRC). However, the mechanism by which NSAIDs suppress colorectal tumorigenesis remains unclear. We previously showed that NSAIDs selectively kill emerging tumor cells via death receptor (DR) signaling and a synthetic lethal interaction mediated by the proapoptotic Bcl-2 family protein BID. In this study, we found NSAIDs induce endoplasmic reticulum (ER) stress to activate DR signaling and BID in tumor suppression. Importantly, our results unveiled an ER stress- and BID-dependent immunogenic effect of NSAIDs, which may be critical for tumor suppression. NSAID treatment induced hallmarks of immunogenic cell death (ICD) in CRC cells and colonic epithelial cells upon loss of APC tumor suppressor, and elevated tumor-infiltrating lymphocytes (TILs) in the polyps of APC

Indexed as

Adenomatous Polyposis Coli ProteinAnimalsAnti-Inflammatory Agents, Non-SteroidalCarcinogenesisColorectal NeoplasmsEndoplasmic ReticulumEndoplasmic Reticulum StressHumansImmunogenic Cell DeathLymphocytes, Tumor-InfiltratingMiceSignal TransductionAdenomatous Polyposis Coli Proteinadenomatous polyposis coli protein, mouseAnti-Inflammatory Agents, Non-SteroidalAPC protein, human

Identifiers

PMID33603166
PMCPMC7981263
OpenAlexW3129455777

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.